National Institutes of Health
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing February 17, 2028.
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or agent that is…